Article Details
Retrieved on: 2022-01-21 17:16:56
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
GlaxoSmithKline and Vir Biotechnology are increasing output at a second plant to help meet demand for sotrovimab.
Article found on: www.wsj.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here